GeneProt to Build Proteomics Facility and Relocate Headquarters to New Jersey | GenomeWeb

NEW YORK, Oct. 3 – GeneProt said Wednesday that it will build a high-throughput proteomics laboratory in North Brunswick, NJ, and relocate its corporate headquarters there from Evanston, Ill.

The new facility, located in The Technology Center, a corporate complex owned by the New Jersey Economic Development Authority (NJEDA), will contain instruments and equipment for separating and analyzing proteins, including supercomputing equipment, GeneProt said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.